ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease clinically classified on the basis of the expression of estrogen and progesterone hormone receptors (ER and PR) and human epidermal growth factor receptor 2 (HER2; encoded by ERBB2), which guides treatment.